Skip to content

The Role of Oral Microbiota Regulation in Radiation-Induced Oral Mucositis and Its Therapeutic Strategies

The Role of Oral Microbiota Regulation in Radiation-Induced Oral Mucositis and Its Therapeutic Strategies

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500114842
Enrollment
Unknown
Registered
2025-12-18
Start date
2024-08-20
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation-Induced Oral Mucositis

Interventions

Pre-irradiation Group :None
2-week Post-irradiation Group with Grade 0/1:None
2-week Post-irradiation Group with Grade 2/3 Ulcers:None

Sponsors

The Third Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Aged 50-80 years (inclusive of 50 and 80 years), regardless of gender; 2.Postoperative status of head and neck cancer, prior to receiving radiotherapy; 3.Development of Grade 0 or 1 oral ulcers two weeks after postoperative radiotherapy for head and neck cancer; 4.Development of Grade 2 or 3 oral ulcers two weeks after postoperative radiotherapy for head and neck cancer; 5.Absence of other oral diseases; 6.Normal mental and psychological status, ability to communicate appropriately and cooperate with the trial; 7. Informed consent obtained, and voluntary written informed consent form signed by the subject.

Exclusion criteria

Exclusion criteria: 1. Patients with HIV, active HBV, or HCV infection; 2.Severe systemic diseases affecting the cardiovascular, pulmonary, hepatic, renal, or hematopoietic systems; 3.Patients receiving concurrent radiotherapy and chemotherapy; 4.Patients who have already taken antibiotics or relevant anti-inflammatory/promotive healing medications; 5.Patients with intellectual, psychiatric, or psychological disorders; 6. Individuals with impaired salivary secretion function who are unable to provide saliva samples.

Design outcomes

Primary

MeasureTime frame
Salivary Microbiota;Oral Mucosal Status;Head and Neck Radiation Dose;

Secondary

MeasureTime frame
Salivary Flow Rate;

Countries

China

Contacts

Public ContactNiu Lina

The Third Affiliated Hospital of Air Force Medical University

niulina831013@126.com+86 29 8477 6001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026